Literature DB >> 2859567

Asthma mortality in New Zealand: a two year national study.

M R Sears, H H Rea, R Beaglehole, A J Gillies, P E Holst, T V O'Donnell, R P Rothwell, D C Sutherland.   

Abstract

The epidemic of deaths from bronchial asthma in New Zealand was investigated by a two-year national review of all deaths of persons under 70 years where "asthma" appeared in part I of a death certificate or in a coroner's report of cause of death. Information about the patients, the characteristics and management of their asthma and the circumstances of the fatal episode was obtained by interviewing relatives and general practitioners and perusal of hospital records. The reviewing panel of the asthma task force of the Medical Research Council considered 271 of the 342 deaths studied were due to asthma. A high national asthma mortality rate (5.1 per 100 000) was confirmed, with rates for Maoris (18.9) and Pacific Islanders (9.4) considerably higher than that for Europeans (3.4 per 100 000). After standardising for age and ethnic groups, there remained a threefold variation in mortality rates among health districts suggesting regional differences in prevalence, severity or management of asthma. No single cause for these high mortality rates was found. One-quarter of the deaths occurred in patients who had had previous life threatening attacks. Excessive use of bronchodilator drugs did not account for the high mortality rates, but inappropriate prolonged use of a home nebuliser may have delayed institution of other therapy in a few cases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2859567

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  43 in total

Review 1.  Beta-agonists and asthma mortality. What have we learned, what questions remain?

Authors:  A J Woolcock
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

Review 2.  Psychosocial aspects of asthma in adults.

Authors:  B D Harrison
Journal:  Thorax       Date:  1998-06       Impact factor: 9.139

3.  Risk of severe life threatening asthma.

Authors:  N C Barnes; L M Kuitert
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 4.  Is current treatment increasing asthma mortality and morbidity?

Authors:  E A Mitchell
Journal:  Thorax       Date:  1989-02       Impact factor: 9.139

5.  75 deaths in asthmatics prescribed home nebulisers.

Authors:  M R Sears; H H Rea; J Fenwick; A J Gillies; P E Holst; T V O'Donnell; R P Rothwell
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

6.  A district confidential enquiry into deaths due to asthma.

Authors:  N J Wareham; B D Harrison; P F Jenkins; J Nicholls; D E Stableforth
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

7.  Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.

Authors:  G N Richards; J Kolbe; J Fenwick; H H Rea
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

8.  Near fatal asthma attacks: the reliability of descriptive information collected from close acquaintances.

Authors:  D A Campbell; G McLennan; J R Coates; P A Frith; P A Gluyas; K M Latimer; A J Martin; D M Roder; R E Ruffin; D Scarce
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

9.  Ethnic differences in prevalence of asthma symptoms and bronchial hyperresponsiveness in New Zealand schoolchildren.

Authors:  P K Pattemore; M I Asher; A C Harrison; E A Mitchell; H H Rea; A W Stewart
Journal:  Thorax       Date:  1989-03       Impact factor: 9.139

10.  The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.

Authors:  A Flatt; J Crane; G Purdie; T Kwong; R Beasley; C Burgess
Journal:  Postgrad Med J       Date:  1990-02       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.